Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla PT Kalbe Farma Tbk.
Okres |
2023-12-31 |
2024-12-31 |
2025-12-31 |
2026-12-31 |
Przychód (średnia) |
30,943,001.85 |
32,540,886.06 |
34,951,182.52 |
37,722,905.74 |
Przychód Δ r/r |
0.00% |
5.16% |
7.41% |
7.93% |
Przychód (min) |
30,616,426.63 |
32,232,538.37 |
34,130,439.11 |
37,091,838.24 |
Przychód (max) |
32,091,572.54 |
32,824,722.00 |
35,916,403.98 |
38,421,022.42 |
EBITDA (średnia) |
5,057,906.63 |
5,319,094.90 |
5,713,079.12 |
6,166,141.73 |
EBIT (średnia) |
4,579,748.43 |
4,816,244.80 |
5,172,983.02 |
5,583,214.55 |
EBIT % |
14.80% |
14.80% |
14.80% |
14.80% |
Zysk netto (średni) |
2,868,591.07 |
3,121,472.22 |
3,495,534.68 |
3,873,581.71 |
Zysk netto % |
9.27% |
9.59% |
10.00% |
10.27% |
EPS (średnia) |
62.10 |
67.48 |
75.44 |
84.11 |
Liczba analityków (Przychody) |
12 |
11 |
11 |
10 |
Liczba analityków (EPS) |
9 |
11 |
10 |
8 |
symbol |
KLBF.JK |
KLBF.JK |
KLBF.JK |
KLBF.JK |